Chronic Lymphocytic Leukemia (CLL) Pipeline Review, H2 2012 New Report
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Chronic Lymphocytic Leukemia (CLL), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Lymphocytic Leukemia (CLL).
View full press release